Metraipolis › archive › dc_95f39fdff25f

A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity — Europe PMC PMID:41631160

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41631160
DOI
10.1016/j.omton.2026.201127
License (as archived)
solo-consultazione
Archived
2026-11-06T22:20:30.571Z
SHA-256 of the archived text
e4225e4c47774bc4b66348fc116f4c820a096d5edc496eab6ea221abf1435103
Stable URL of this page
https://metraipolis.com/documento/dc_95f39fdff25f

How to cite

A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity — Europe PMC PMID:41631160 — Europe PMC (en), https://europepmc.org/article/MED/41631160 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_95f39fdff25f (Metraipolis archive dc_95f39fdff25f, sha256 e4225e4c47774bc4b66348fc116f4c820a096d5edc496eab6ea221abf1435103)
BibTeX
@misc{dc95f39fdff25f,
  title = {A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity — Europe PMC PMID:41631160},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41631160},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_95f39fdff25f; sha256 e4225e4c47774bc4b66348fc116f4c820a096d5edc496eab6ea221abf1435103},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41631160. Agents can read the archived copy with the MCP tool read_document.